TNPSC Thervupettagam

Approval of Omicron vaccine

August 19 , 2022 703 days 676 0
  • Britain has become the first country to authorise a Covid-19 vaccine that targets the Omicron variant.
  • The UK medicine regulator approved the 'bivalent' vaccine made by Moderna as a booster for adults.
  • This vaccine triggered "a strong immune response" against both Omicron (BA.1) and the original 2020 virus.
  • It also generates a good immune response against the currently dominant Omicron sub-variants BA.4 and BA.5.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories